SAN FRANCISCO, March 7, 2018 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) Senior Vice President and Chief ScientificOfficer, Jonathan Zalevsky, Ph.D., is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference in Boston on Wednesday, March 14, 2018 at 8:00 a.m. Eastern Time.
Nektar Therapeutics is a research-based, development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, autoimmune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
InvestorsJennifer Ruddock of Nektar Therapeutics415-482-5585
View original content:http://www.prnewswire.com/news-releases/nektar-to-webcast-presentation-at-the-cowen-and-company-38th-annual-health-care-conference-in-boston-300609620.html
SOURCE Nektar Therapeutics
Subscribe to our Free Newsletters!
Prunes are dried plums that are packed with nutrients like vitamins and minerals that are essential ...
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...View All